Product Information
LITHIUM 8 MEQ/5 ML SOLUTION is a generic product labeled by Advagen Pharma Ltd., priced at $0.4798 per ML under NDC 72888017246. Its NADAC has been published 46 times since Aug 20, 2025.
Strength
8 meq/5mL
Manufacturer
Advagen Pharma Ltd.NDC
72888017246
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LITHIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA218036On Market Since
11/9/2022
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM 8 MEQ/5 ML SOLUTION has been published 46 times since Aug 20, 2025, and over the history we have for it it has risen 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4798 per ML |
|---|---|
| All-time high | $0.4808 (May 13, 2026) |
| All-time low | $0.4698 (Aug 20, 2025) |
| 52-week high | $0.4808 |
| 52-week low | $0.4698 |
| Median price | $0.4768 |
| Average price | $0.4762 |
| Largest weekly change | +0.8% (Jan 21, 2026) |
| Weeks tracked | 46 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Lithium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LITHIUM 8 MEQ/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM 8 MEQ/5 ML SOLUTION, manufactured by Advagen Pharma Ltd., is $0.4798 per ML (NDC 72888017246), effective Jul 1, 2026.
How has the price of LITHIUM 8 MEQ/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for LITHIUM 8 MEQ/5 ML SOLUTION has risen 2.1%. It has been tracked across 46 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for LITHIUM 8 MEQ/5 ML SOLUTION?
Since Aug 20, 2025, the NADAC for LITHIUM 8 MEQ/5 ML SOLUTION has ranged from a low of $0.4698 (Aug 20, 2025) to a high of $0.4808 (May 13, 2026), with a median of $0.4768 per ML.
Are there cheaper alternatives to LITHIUM 8 MEQ/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LITHIUM 8 MEQ/5 ML SOLUTION, so no direct lower-cost alternative is listed.
Who manufactures LITHIUM 8 MEQ/5 ML SOLUTION?
LITHIUM 8 MEQ/5 ML SOLUTION (NDC 72888017246) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification